BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25380083)

  • 1. Positron emission tomography combined with computed tomography as a screening tool for occult malignancy in patients with unprovoked venous thromboembolism: an observational study.
    Chauchard M; Benali K; Papo T; Sacre K
    Medicine (Baltimore); 2014 Nov; 93(21):e110. PubMed ID: 25380083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A pilot study utilizing whole body 18 F-FDG-PET/CT as a comprehensive screening strategy for occult malignancy in patients with unprovoked venous thromboembolism.
    Rondina MT; Wanner N; Pendleton RC; Kraiss LW; Vinik R; Zimmerman GA; Heilbrun M; Hoffman JM; Morton KA
    Thromb Res; 2012 Jan; 129(1):22-7. PubMed ID: 21802118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited screening with versus without (18)F-fluorodeoxyglucose PET/CT for occult malignancy in unprovoked venous thromboembolism: an open-label randomised controlled trial.
    Robin P; Le Roux PY; Planquette B; Accassat S; Roy PM; Couturaud F; Ghazzar N; Prevot-Bitot N; Couturier O; Delluc A; Sanchez O; Tardy B; Le Gal G; Salaun PY;
    Lancet Oncol; 2016 Feb; 17(2):193-199. PubMed ID: 26672686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Screening for occult malignancy with FDG-PET/CT in patients with unprovoked venous thromboembolism.
    Alfonso A; Redondo M; Rubio T; Del Olmo B; Rodríguez-Wilhelmi P; García-Velloso MJ; Richter JA; Páramo JA; Lecumberri R
    Int J Cancer; 2013 Nov; 133(9):2157-64. PubMed ID: 23616232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Performance of 18F-fluorodesoxyglucose positron-emission tomography combined with low-dose computed tomography for cancer screening in patients with unprovoked venous thromboembolism.
    Robin P; Le Roux PY; Lacut K; Planquette B; Prévot-Bitot N; Lavigne C; Pastre J; Merah A; Le Gal G; Salaun PY
    PLoS One; 2017; 12(6):e0178849. PubMed ID: 28570648
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Additional testing following screening strategies for occult malignancy diagnosis in patients with unprovoked venous thromboembolism.
    Robin P; Le Roux PY; Le Moigne E; Planquette B; Prévot-Bitot N; Roy PM; Pastre J; Merah A; Couturaud F; Le Gal G; Salaun PY
    Thromb Res; 2017 Jul; 155():6-9. PubMed ID: 28460260
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of testing for cancer on cancer- and venous thromboembolism (VTE)-related mortality and morbidity in people with unprovoked VTE.
    Robertson L; Yeoh SE; Stansby G; Agarwal R
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD010837. PubMed ID: 28832905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In patients with unprovoked VTE, does the addition of FDG PET/CT to a limited occult cancer screening strategy offer good value for money? A cost-effectiveness analysis from the publicly funded health care systems.
    Robin P; Kumar S; Salaun PY; Le Roux PY; Couturaud F; Planquette B; Merah A; Roy PM; Thavorn K; Le Gal G
    Thromb Res; 2018 Nov; 171():97-102. PubMed ID: 30268859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utility of additional abdominopelvic CT in detecting occult cancer in patients with unprovoked venous thromboembolism.
    Vaidyanathan S; Walsh J; Cliffe H; Saleem N; Weston MJ; Lowe AS; Chowdhury FU
    Clin Radiol; 2016 Jun; 71(6):501-6. PubMed ID: 27005017
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unprovoked venous thromboembolism in women over 40: is screening for occult malignancy with mammography and abdominopelvic CT of benefit?
    Healy NA; Daley FC; Sinnatamby R
    Clin Radiol; 2020 Oct; 75(10):757-762. PubMed ID: 32646605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance of
    Robin P; van Es N; Le Roux PY; Rondina M; Lecumberri R; Beckers M; Le Gal G; Salaun PY
    Thromb Res; 2020 Oct; 194():153-157. PubMed ID: 32788108
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Delluc A; Robin P
    Thromb Res; 2022 May; 213 Suppl 1():S42-S45. PubMed ID: 36210560
    [No Abstract]   [Full Text] [Related]  

  • 13. Investigation of unprovoked venous thromboembolism: a case for a tempered approach?
    Hussain TI; Stephenson JA; Das B; Naqvi S; Verma R; Barnes D
    Clin Radiol; 2016 Oct; 71(10):1005-1009. PubMed ID: 27237325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extensive Computed Tomography versus Limited Screening for Detection of Occult Cancer in Unprovoked Venous Thromboembolism: A Multicenter, Controlled, Randomized Clinical Trial.
    Prandoni P; Bernardi E; Valle FD; Visonà A; Tropeano PF; Bova C; Bucherini E; Islam MS; Piccioli A
    Semin Thromb Hemost; 2016 Nov; 42(8):884-890. PubMed ID: 27764880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CT imaging for occult malignancy in patients with unprovoked venous thromboembolism (VTE) in a tertiary centre: is it worthwhile?
    Lee RJ; Herlihy D; O'Neill DC; Madden-Doyle L; Morrin M; Lee MJ
    Ir J Med Sci; 2023 Dec; 192(6):3081-3086. PubMed ID: 36849651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensive screening for occult malignancy in unprovoked venous thromboembolism: A meta-analysis.
    Zhou M; Zhang L; Ding Y; Wang Y; Yan D; Lin C; Shi Z; Fu W
    Thromb Res; 2017 Sep; 157():147-153. PubMed ID: 28753478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implementation of NICE recommendations on abdomino-pelvic CT, following unprovoked venous thromboembolism, in a UK teaching hospital: no additional detection of occult malignancy and high numbers of incidental findings.
    Garwood D; Renton BJ; Joekes E
    Acute Med; 2016; 15(5):25-9. PubMed ID: 27116584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost effectiveness of the addition of a comprehensive CT scan to the abdomen and pelvis for the detection of cancer after unprovoked venous thromboembolism.
    Coyle K; Carrier M; Lazo-Langner A; Shivakumar S; Zarychanski R; Tagalakis V; Solymoss S; Routhier N; Douketis J; Coyle D
    Thromb Res; 2017 Mar; 151():67-71. PubMed ID: 28160670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Occult cancer and thromboembolism: current epidemiology and its practical implications.
    Chao CH; Wang HY; Kao CH
    Pol Arch Intern Med; 2018 Sep; 128(9):539-544. PubMed ID: 30057385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venous thromboembolism and occult cancer: impact on clinical practice.
    Gheshmy A; Carrier M
    Thromb Res; 2016 Apr; 140 Suppl 1():S8-11. PubMed ID: 27067984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.